Fortrea
Jirí Létal is a seasoned biostatistician with extensive experience in leading statistical activities for clinical studies across various companies. Currently serving as Principal Biostatistician at Fortrea since May 2023, Jirí provides statistical oversight and develops complex analysis plans. In addition, Jirí works as a Statistical Consultant for Wound Market Consulting, offering expertise in biotech study design and statistical analysis. Past roles include Principal Biostatistician at PRA Health Sciences, Navitas Life Sciences, and Grünenthal Group, as well as contract positions at Janssen and earlier consultancy with Wound Market Consulting. Jirí's educational background includes a Ph.D. in Biometrics for Horticulture Science from Mendel University and a Master of Science in Mathematics from Masaryk University.
This person is not in any teams
This person is not in any offices
Fortrea
11 followers
Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development and patient access solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients in need. Fortrea provides phase I-IV clinical trial management, clinical pharmacology, differentiated technology-enabled trial solutions and post-approval services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team of approximately 19,000 people working in more than 90 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at Fortrea.com.